Share this page:

Circadian Thermal Sensing for the Detection of Breast Disease as a Supplemental Cancer Screening System

The purpose of this study is to determine if the Cyrcadia device can predict if a woman has breast cancer or benign breast tissue.

Skip to main content

Phase: Pilot/Feasibility
Status: Recruiting

The purpose of this study is to determine if the Cyrcadia device can predict if a woman has breast cancer or benign breast tissue.  The Cyrcadia device includes two adhesive patches with electrodes that are fitted over each breast. It collects data on the dynamic temperature changes in the breasts over time and transfers acquired data to a processing location which will return results to your physician. To determine the accuracy of this device, it will be tested on a group of women who have been scheduled for a breast biopsy due to a suspicious imaging test.

Principal Investigator

Shiva Singhal, MD

Sponsor

Cyrcadia, Inc.

NCT Number

NCT02511301

Contact

Kathy Miller, Clinical Research Coordinator
Taft Center for Clinical Research
650-962-4562
kathryn_miller@elcaminohealth.org

For more information about this clinical trial, including trial status, eligibility and full trial listing, visit www.clinicaltrials.gov.